Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Chloride for Prevention of Uterine Atony During Cesarean Section
NCT03867383Phase 2Completed
- Sponsor
- Stanford University
- Start
- Mar 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of calcium chloride in uterine atony and postpartum hemorrhage (PPH), sponsored by Stanford University. Primary endpoint: Incidence of Uterine Atony at 4 hours. Started Mar 2019; status: completed.
02
Drugs
calcium chloride
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03867383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03867383.